Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone may worsen hair loss by affecting hair growth signals, while different prostaglandins can either hinder or promote hair growth.

Bimatoprost can cause longer, thicker, darker eyelashes and eyebrows.

Hair loss can be treated with common methods like minoxidil and finasteride, but new potential treatments include growth factors, cytokines, and platelet-rich plasma injections.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

A woman got unwanted hair growth on her face from using bimatoprost eyedrops for glaucoma.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

Bimatoprost 0.01% effectively and safely improves eyebrow growth.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.

Low-dose oral minoxidil can improve hair and eyebrow growth in frontal fibrosing alopecia.

Topical prostaglandin analogs may help with hair growth but more research is needed.

Lasers might help hair growth in some alopecia cases, but more research is needed to confirm their effectiveness and safety.

A substance called prostaglandin D2 is linked to stopping hair growth in men with common baldness.

A substance called compound-1 could help increase hair growth by maintaining prostaglandin levels in hair follicles.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

Latanoprost may be a promising new treatment for hair loss.

A young girl developed unusually long eyelashes with a hair loss condition without other health issues or medication causes.

Bimatoprost 0.03% is as effective as minoxidil 2% for eyebrow growth.

Spanlastic-laden nanogel could be a better way to deliver hair growth medication through the skin for treating hair loss.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

A new treatment for hair loss uses tiny lipid carriers to deliver a mix of minoxidil and latanoprost directly to hair follicles, promoting hair growth and being well tolerated by the skin.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Hair follicle culture helps develop new treatments for hair loss.

Bimatoprost effectively and safely improves eyebrow appearance.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Minoxidil is the main over-the-counter treatment for hair loss, with other options like finasteride, latanoprost, retinoic acid, antioxidants, biotin, nutraceuticals, and platelet-rich plasma therapy also showing promise.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

Hair changes can indicate systemic diseases or medication effects.